Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This investigational treatment, developed by Minia University, is a local drug delivery system designed to treat gingival recession. It consists of a prefabricated mucoadhesive membrane, formulated with Carbopol polymers (carbomers), that serves as a vehicle for the sustained release of ascorbic acid (Vitamin C) directly to the affected gingival tissues. Ascorbic acid is a critical cofactor for the enzymes prolyl hydroxylase and lysyl hydroxylase, which are essential for the post-translational modification and stabilization of collagen fibers. By enhancing collagen synthesis and providing antioxidant protection against oxidative stress in periodontal tissues, the treatment aims to promote gingival healing and curtail the progression of recession, potentially offering a non-surgical alternative to traditional soft tissue grafts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ascorbic acid-loaded membrane.